Science Explorer Back to mapMap
Discussion
Company · Gifu City · Japan

API (Japan)

api3838.co.jp/enROR OpenAlex
Research works
12
▼ 70% vs 2018-21
Citations
390
33.3 per fractional work
Top-10% rate
10.0%
all institutions 10.0%
Open access
43%
world 40%
International
11%
world 18%
API (Japan)

Not ranked overall: API (Japan) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does API (Japan) work in?

In all years, 63% of research at API (Japan) is in Life Sciences, 21% in Health Sciences. Its largest fields are Agricultural and Biological Sciences (33%), Biochemistry, Genetics and Molecular Biology (27%), Medicine (18%). It does 2.2× the world's share of Life Sciences.

Life Sciences: 7 fractional works · 63.4% of its workAgricultural and Biological Sciences: 4 fractional works · 33.2% of its workInsect Science: 2 fractional works · 13.6% of its workPlant Science: 1 fractional works · 7.9% of its workFood Science: 1 fractional works · 7.4% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 3.4% of its workAnimal Science and Zoology: 0 fractional works · 0.9% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 26.9% of its workMolecular Biology: 2 fractional works · 15.4% of its workPhysiology: 0 fractional works · 4.3% of its workGenetics: 0 fractional works · 3.4% of its workBiotechnology: 0 fractional works · 1.6% of its workBiochemistry: 0 fractional works · 0.7% of its workCell Biology: 0 fractional works · 0.7% of its workClinical Biochemistry: 0 fractional works · 0.7% of its workImmunology and Microbiology: 0 fractional works · 2.7% of its workImmunology: 0 fractional works · 2.7% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.6% of its workPharmacology: 0 fractional works · 0.6% of its workHealth Sciences: 2 fractional works · 21.2% of its workMedicine: 2 fractional works · 17.8% of its workPharmacology: 1 fractional works · 5.5% of its workInfectious Diseases: 0 fractional works · 2.8% of its workSurgery: 0 fractional works · 2.3% of its workComplementary and alternative medicine: 0 fractional works · 1.5% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 1.5% of its workOphthalmology: 0 fractional works · 1.5% of its workOncology: 0 fractional works · 1.3% of its workPhysiology: 0 fractional works · 1.2% of its workGeriatrics and Gerontology: 0 fractional works · 0.5% of its workVeterinary: 0 fractional works · 2.8% of its workSmall Animals: 0 fractional works · 2.8% of its workHealth Professions: 0 fractional works · 0.6% of its workComplementary and Manual Therapy: 0 fractional works · 0.3% of its workSpeech and Hearing: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 2 fractional works · 15.4% of its workChemistry: 1 fractional works · 12.6% of its workOrganic Chemistry: 1 fractional works · 10.7% of its workInorganic Chemistry: 0 fractional works · 1.9% of its workEnvironmental Science: 0 fractional works · 2.8% of its workPollution: 0 fractional works · 2.8% of its workALL ITS WORKAPI (Japan)12fractional works, all years
Life Sciences63%Physical Sciences15%Health Sciences21%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 9 fields, with their numbers
    1. Agricultural and Biological Sciences433.2%
    2. Biochemistry, Genetics and Molecular Biology326.9%
    3. Immunology and Microbiology02.7%
    4. Pharmacology, Toxicology and Pharmaceutics00.6%
    1. Medicine217.8%
    2. Veterinary02.8%
    3. Health Professions00.6%
    1. Chemistry112.6%
    2. Environmental Science02.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from API (Japan)?

The most cited paper from API (Japan) is "Water extract of propolis and its main constituents, caffeoylquinic acid derivatives, exert neuroprotective effects via antioxidant actions" (Yoshimi Nakajima, Masamitsu Shimazawa, Satoshi Mishima et al., 2006), with 234 citations. Next come "Neuroprotection by Brazilian Green Propolis against In vitro and In vivo Ischemic Neuronal Damage" (116) and "Bilberry and its main constituents have neuroprotective effects against retinal neuronal damagein vitroandin vivo" (99).

Most cited papers
#PaperReleasedCitations
1 Water extract of propolis and its main constituents, caffeoylquinic acid derivatives, exert neuroprotective effects via antioxidant actions Yoshimi Nakajima, Masamitsu Shimazawa, Satoshi Mishima et al. · Life Sciences 24 Sep 2006 234
2 Neuroprotection by Brazilian Green Propolis against In vitro and In vivo Ischemic Neuronal Damage Masamitsu Shimazawa, Satomi Chikamatsu, Nobutaka Morimoto et al. · Evidence-based Complementary and Alternative Medicine Open access 2005 116
3 Bilberry and its main constituents have neuroprotective effects against retinal neuronal damagein vitroandin vivo Nozomu Matsunaga, Shunsuke Imai, Yuta Inokuchi et al. · Molecular Nutrition & Food Research 4 May 2009 99
4 Reproductive disturbance of Japanese bumblebees by the introduced European bumblebee Bombus terrestris Natsuko Ito Kondo, Daisei Yamanaka, Yuya Kanbe et al. · Die Naturwissenschaften 12 Dec 2008 74
5 Brazilian Green Propolis Protects against Retinal Damage In Vitro and In Vivo Yuta Inokuchi, Masamitsu Shimazawa, Yoshimi Nakajima et al. · Evidence-based Complementary and Alternative Medicine Open access 2006 72
All 27 most cited papers, with filters and sorting

Which research topics does API (Japan) publish most on?

By volume in 2022-now: Angiogenesis and VEGF in Cancer, Lymphatic Disorders and Treatments, Lymphatic System and Diseases and Cervical and Thoracic Myelopathy.

Angiogenesis and VEGF in…0Angiogenesis and VEGF in Cancer: 0 fractional worksLymphatic Disorders and …0Lymphatic Disorders and Treatments: 0 fractional worksLymphatic System and Dis…0Lymphatic System and Diseases: 0 fractional works
Molecular BiologySurgeryOncology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Angiogenesis and VEGF in Cancer Molecular Biology 0 works
  2. 2 Lymphatic Disorders and Treatments Surgery 0 works
  3. 3 Lymphatic System and Diseases Oncology 0 works
  4. 4 Cervical and Thoracic Myelopathy Surgery 0 works
  5. 5 Temporomandibular Joint Disorders Complementary and Manual Therapy 0 works
  6. 6 Dysphagia Assessment and Management Speech and Hearing 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available43.3%not open56.7%

World: 40% of research is openly available.

with international co-authors11.1%domestic only88.9%

World: 18% is written across borders.

How has API (Japan)'s research output changed?

Output in 2022-2025 was 70% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is API (Japan) as a percentage of every work published that year, 0.0000038% in 2022.

still counting0.00010%0.00020%API (Japan)0.0000017% in 2025200020102020

Fractional works of API (Japan) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Gifu City

All research institutions in Gifu City

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about API (Japan). Posts are plain text and can be reported.